Status:
COMPLETED
Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia
Lead Sponsor:
Benha University
Conditions:
Omega 3
Treatment
Eligibility:
All Genders
12-16 years
Phase:
NA
Brief Summary
This study aimed to evaluate the effect of omega-3 supplementation on heart rate (HR) control and heart rate variability (HRV) in children with inappropriate sinus tachycardia (IST).
Detailed Description
Inappropriate sinus tachycardia (IST) is a is a common disease of the autonomic nervous system in children in which tachyarrhythmia characterized by a persistent increase in resting sinus rate or disp...
Eligibility Criteria
Inclusion
- Age from 12 to 16 years.
- Both sexes.
- Patients diagnosed with inappropriate sinus tachycardia (IST).
- Patients with resting heart rate (HR) ≥100 bpm (sitting) and/or 24-hour average HR ≥90.
Exclusion
- Structural heart disease.
- Patients receiving antiarrhythmic medication.
- Patients with a prior history of arrhythmias such as paroxysmal supraventricular tachycardia (PSVT) or sick sinus syndrome, or orthostatic hypotension.
- Secondary conditions such as anemia, infection, or hyperthyroidism.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07138131
Start Date
October 1 2023
End Date
September 1 2024
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benha University
Banhā, Al-Qalyubia, Egypt, 13518